Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 17, 2019
Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010Shahab Abtahi, Johanna H M Driessen, Peter Vestergaard, et al.
Archives of Osteoporosis|March 20, 2018
Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control studyM Amine Amiche, Shahab Abtahi, Johanna H M Driessen, et al.
Annals of the Rheumatic Diseases|December 14, 2020
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort studyShahab Abtahi, Johanna H M Driessen, Andrea M Burden, et al.
Cancer Epidemiology|April 16, 2022
Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitorsArd van Veelen, Shahab Abtahi, Patrick Souverein, et al.
Rheumatology (Oxford, England)|July 13, 2021
Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research DatalinkShahab Abtahi, Johanna H M Driessen, Andrea M Burden, et al.
British Journal of Clinical Pharmacology|August 19, 2024
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant usersDitte B Iversen, Ann-Cathrine Dalgård Dunvald, Martin Thomsen Ernst, et al.
Vaccine|January 5, 2024
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member statesCaroline Buhl, Ramune Jacobsen, Anna Birna Almarsdóttir, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare ProfessionalsElla van Vliet, Nanča Čebron Lipovec, Marloes van der Goot, et al.
Drug Safety|June 9, 2023
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series StudyShahab Abtahi, Romin Pajouheshnia, Carlos E Durán, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Pageof 3